Company intelligence / Profile preview
Beijing Wanter Bio-Pharmaceutical Co., Ltd.
Beijing, Beijing, Chinaystwt.cn ↗
- Ownership
- Private
- Employees
- ~100
- Development stage
- Commercial
01
Overview
Beijing Wanter Bio‑Pharmaceutical is a Chinese biopharma company focused on neoplasms and infectious diseases. It has an approved drug targeting Pseudomonas aeruginosa for bacterial infections in China since April 2004. The company also has a discovery-stage monoclonal antibody program targeting PD‑1 for cancer indications. No detailed clinical results are publicly available.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Microbiota-based therapeuticsMonoclonal antibodies
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on Beijing Wanter Bio-Pharmaceutical Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Beijing Wanter Bio-Pharmaceutical Co., Ltd..